Epilepsy Drugmaker's Statements Insulated From Stock Suit
By P.J. D'Annunzio · March 12, 2026, 5:10 PM EDT
A Pennsylvania federal judge has trimmed a shareholder class action against Marinus Pharmaceuticals alleging it misled investors about the probability of success of an epilepsy drug, ruling that certain statements made...
To view the full article, register now.